Alpha Tau Medical Ltd. Ordinary Shares
DRTS
Closed
$13.00
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.
Key stats
Open
$12.53
Volume
407.50K
Market cap
$1.12B
Prev. close
$12.98
Impl / hst vl
-
Open interest
$0.00
$12.52
Day’s Range
$13.28
$4.75
52W Range
$14.11
Valuation
33
Valuation score
Overvalued
P/E
-
P/S
-
P/B
16.22
Current ratio
7.79
Debt / Equity
0.03
ROE
-73.23%
Gross margin
-
Income growth
89.02%
FCF growth
-
Analysts estimates
Consensus rating
Buy
The average rating from top 5 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$14.48
The top 7 analysts forecasts that 12-month price may increase by 11.42%, with a low of $8.08 and a high of $17.85
$8.08
Low
$14.48
Avg
$17.85
High
Current price
Earnings
Q1 ‘26 revenue
$0.00
Q1 ‘26 net income
-$22.94M
Revenue
Net income
Previous EPS
-$0.08
Estimate EPS
-$0.13
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply